ArticleFrontiers in oncology2022

Dramatic response to neoadjuvant savolitinib in marginally resectable lung adenocarcinoma with MET exon 14 skipping mutation: A case report and literature review.

Jiangfang Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.